Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,108 | 186 | 53.0% |
| Consulting Fee | $1,820 | 1 | 23.5% |
| Travel and Lodging | $1,593 | 4 | 20.6% |
| Education | $223.20 | 7 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Keryx Biopharmaceuticals, Inc. | $3,604 | 9 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $977.27 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $354.16 | 21 | $0 (2024) |
| Amgen Inc. | $349.21 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $334.91 | 16 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $213.97 | 14 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $213.75 | 10 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $163.13 | 10 | $0 (2023) |
| Vifor Pharma, Inc. | $162.01 | 8 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $123.17 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $705.82 | 39 | Otsuka America Pharmaceutical, Inc. ($169.62) |
| 2023 | $572.10 | 30 | Vifor Pharma, Inc. ($111.11) |
| 2022 | $479.73 | 26 | Otsuka America Pharmaceutical, Inc. ($67.22) |
| 2021 | $299.60 | 16 | AstraZeneca Pharmaceuticals LP ($64.57) |
| 2020 | $229.21 | 15 | Amgen Inc. ($73.32) |
| 2019 | $647.95 | 25 | Fresenius USA Marketing, Inc. ($246.43) |
| 2018 | $3,906 | 28 | Keryx Biopharmaceuticals, Inc. ($3,604) |
| 2017 | $904.00 | 19 | Fresenius USA Marketing, Inc. ($530.63) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.29 | General |
| 10/31/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: NEPHROLOGY | ||||||
| 08/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEPHROLOGY | ||||||
| 07/23/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Renal | ||||||
| 07/03/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEPHROLOGY | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.49 | General |
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEPHROLOGY | ||||||
| 05/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DIABETES | ||||||
| 05/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: NEPHROLOGY | ||||||
| 04/01/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.94 | General |
| 03/28/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,355 | 3,615 | $815,249 | $219,021 |
| 2022 | 17 | 2,476 | 3,950 | $956,020 | $258,872 |
| 2021 | 20 | 2,875 | 4,693 | $1.4M | $401,517 |
| 2020 | 22 | 3,398 | 5,794 | $1.7M | $437,850 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 71 | 341 | $347,820 | $89,472 | 25.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 19 | 128 | $110,592 | $28,361 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 275 | $41,800 | $13,304 | 31.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 36 | 61 | $52,521 | $13,097 | 24.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 80 | $24,000 | $9,977 | 41.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 112 | $16,912 | $9,847 | 58.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 165 | $17,490 | $9,639 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 130 | $28,990 | $8,979 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $18,411 | $8,179 | 44.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 79 | 134 | $35,644 | $7,113 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 332 | 492 | $4,920 | $4,104 | 83.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 331 | 480 | $37,920 | $3,631 | 9.6% |
| 80069 | Kidney function blood test panel | Office | 2023 | 249 | 376 | $34,592 | $3,190 | 9.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 32 | $6,880 | $3,022 | 43.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 29 | $7,714 | $1,770 | 22.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 317 | 452 | $9,944 | $1,532 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $2,619 | $1,355 | 51.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 105 | 108 | $12,096 | $1,111 | 9.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 29 | 29 | $2,030 | $841.29 | 41.4% |
| 84100 | Phosphate level | Office | 2023 | 104 | 107 | $2,354 | $494.58 | 21.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 84 | 405 | $413,100 | $105,360 | 25.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 19 | 121 | $104,544 | $27,837 | 26.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 66 | 114 | $98,154 | $24,783 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 170 | 361 | $38,266 | $18,288 | 47.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 117 | 128 | $38,400 | $18,095 | 47.1% |
About Dr. Marcus Britton, M.D
Dr. Marcus Britton, M.D is a Nephrology healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003842378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Britton, M.D has received a total of $7,744 in payments from pharmaceutical and medical device companies, with $705.82 received in 2024. These payments were reported across 198 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,108).
As a Medicare-enrolled provider, Britton has provided services to 11,104 Medicare beneficiaries, totaling 18,052 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine, Internal Medicine
- Location Tupelo, MS
- Active Since 06/25/2006
- Last Updated 05/22/2009
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1003842378
Products in Payments
- Auryxia (Drug) $3,688
- Not Product Related (Medical Supply) $481.83
- JYNARQUE (Drug) $350.83
- FARXIGA (Drug) $226.67
- Velphoro (Drug) $220.15
- ACTHAR (Biological) $192.08
- Veltassa (Drug) $150.96
- AURYXIA (Drug) $129.70
- LOKELMA (Drug) $127.49
- Kerendia (Drug) $123.17
- Parsabiv (Drug) $120.84
- LUPKYNIS (Drug) $120.23
- Parsabiv (Biological) $110.95
- Rayaldee (Drug) $108.83
- RAYALDEE (Drug) $105.14
- Da Vinci Surgical System (Device) $96.29
- BENLYSTA (Biological) $83.13
- ZEPATIER (Drug) $82.47
- System One (Device) $71.49
- KRYSTEXXA (Biological) $57.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Tupelo
Thomas Wooldridge, Md, MD
Nephrology — Payments: $15,994
Morris Hamilton, Md, MD
Nephrology — Payments: $6,265
John Lee, Md, MD
Nephrology — Payments: $5,824
Christopher Miller
Nephrology — Payments: $5,057
Tzonko Milev, Md, MD
Nephrology — Payments: $4,673
John Elliott, D.o, D.O
Nephrology — Payments: $4,032